Oral Antibiotics in Patients with Short Bowel Syndrome: Hurdles and Caveats
Eur J Drug Metab Pharmacokinet
.
2021 Nov;46(6):825-826.
doi: 10.1007/s13318-021-00717-w.
Epub 2021 Oct 5.
Authors
Lawrence Siu-Chun Law
1
,
Wallace Bok-Thoe Hong
2
,
Siang Fei Yeoh
1
,
Wee Kiat Tan
1
,
David Eng-Hui Ong
3
,
Elaine Ah-Gi Lo
4
Affiliations
1
National University Hospital, National University Health System, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore.
2
Imperial College School of Medicine, South Kensington, London, SW7 2DD, UK.
3
Department of Medicine, National University of Singapore, 21 Lower Kent Ridge Road, Singapore, 119077, Singapore.
4
National University Hospital, National University Health System, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore. elaine_lo@nuhs.edu.sg.
PMID:
34609730
DOI:
10.1007/s13318-021-00717-w
No abstract available
Publication types
Letter
MeSH terms
Administration, Oral
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / pharmacokinetics*
Humans
Short Bowel Syndrome / drug therapy*
Short Bowel Syndrome / metabolism*
Substances
Anti-Bacterial Agents